Device Trial Radar · NCT03077516
Post-Market, Long-Term Follow Up of Mobi-C® Cervical Disc for One and Two Level Treatment of Cervical Disc Disease
Last checked: Nov 20, 2026Latest source record: Dec 4, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
216
Actual
Start
Nov 2016
Primary completion
Oct 31, 2019
Study completion Oct 31, 2019
Sponsor
- Lead sponsor
- LDR Spine USANot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 13, 2017
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate clinical and patient-reported outcomes at 10 years following surgery for a cohort of Mobi-C subjects treated on the IDE/Post Approval studies
Conditions
- Cervical Disc Disease
- Cervical Disc Degeneration
Interventions
Mobi-CDevice
Device for cervical intervertebral disc replacement at one or two contiguous levels
Primary outcomes
What the sponsor says the trial is designed to measure.
- NDI ScoreTime frame: 10 Years
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Orange County Neurosurgical Associates
Laguna Hills, California
7 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.